Alternatives to TellHerDoc

The widest menu on this list — injections, lozenges, drops and a brand-name lane — with a flat price that genuinely holds as your dose climbs. The catch is the exit: every plan locks you in for two months.

RxSpan MD is a genuinely well-disclosed service wrapped in marketing that undercuts it. The disclosure: four compounding pharmacies named with phone numbers, two lead physicians named with NPI numbers that verify as active MDs, flat pricing posted before any intake, both compounded and real FDA-approved brand GLP-1s on one platform, and oral capsules for anyone who won't inject. Compounded semaglutide is $249 a month and tirzepatide $329, with brand Zepbound at $1,069, Ozempic at $1,299 and Wegovy at $1,349. The marketing is the problem. Its testimonials still name a different company — one patient describes what she 'expected from CareGLP' — and the doctors quoted in them are not the clinicians the same page names as its medical team. The homepage is built around a board-certified plastic surgeon who founded the practice but is licensed in California only and isn't the prescriber. Its compounded prices also sit above the roster median, and the oral capsules cost the same or more than the injections.

Pallas Health removes the two things that usually cost a working parent the most time: it publishes every price before intake, and it runs care asynchronously in 43 of 50 states, so there's no video appointment to wedge into a workday. Compounded semaglutide averages about $199 a month and tirzepatide $299, and unusually the genuine FDA-approved pens sit alongside them — Zepbound $1,069, Ozempic $1,299, Wegovy and Mounjaro $1,349 — all cash-pay from the same clinician. The price is flat at every dose, so a titration never produces a surprise bill, and the plan figure already contains the clinician, dose adjustments, check-ins and messaging with no membership fee. Its cancellation terms are unusually concrete: cancel free through the portal, keep access to the end of the paid period, full refund if a clinician declines you, and a $5 processing fee on a qualifying refund. The trade-offs are that billing lands every 12 weeks in $597 and $897 blocks rather than monthly, the compounding pharmacy is never named, and insurance is never billed.

A fast, fully async start with a needle-free sublingual tirzepatide option and — a genuine upgrade since our last check — flat pricing stated in writing. The catch is a state list it still won't publish.

AskRx solves the pricing question most of this page leaves open, and creates a different one. Its care fee is itemized in its own footnote — $90/month physician visit, $10/month fulfilment, $100 total — and the medication is billed separately through its own pharmacy, at cost, with both halves shown at checkout. If you have ever wondered how much of a blended monthly price is the drug and how much is margin, this is the provider that answers it. It is FDA-approved only ('No compounded meds'), so the options are the Wegovy pen, the Wegovy pill, Zepbound in pen or KwikPen form, and Foundayo, the oral tirzepatide. All 50 states, board-certified physicians with obesity-medicine training, unlimited messaging, monthly titration, cancel anytime. Two logistics notes that matter on a workday. First, $100 is a floor: no medication price is published, so your real monthly total is unknown until checkout and depends on coverage. Second — and read this one if scheduling is your constraint — 'video visits available in select states' means the async route is not universal here, so confirm your own state before assuming you can do this without a call.

One flat $195/mo plan covers compounded semaglutide, compounded tirzepatide, or a needle-free sublingual option — plus real brand-name access if you want an FDA-approved pen instead — with a women's-health-first framing and a $99 first month, though it won't name your state until you're inside the signup flow.

Compounded semaglutide at $199 a month and tirzepatide at $299, the same price at every dose, and the daily tablet costs the same as the injection on both — all of it on an open pricing page you reach without a quiz. Brand-name prices are published too, which is rare: Wegovy $999, Ozempic $899, Mounjaro $999, cash. Two things to know before you enter a card. The badge at the top of every page says no subscription, and its own FAQ then asks whether you can cancel your subscription and tells you to call before your next billing date — so it does recur, whatever the badge says. And nothing anywhere on the site says how many weeks of medication one $199 charge actually buys. It ships to all 50 states, and it carries a June 2026 FDA warning letter for false or misleading claims, which it has since fixed.

A cardiometabolic telehealth platform built around diabetes care that also treats obesity — $149/mo self-pay or free with insurance, one price covering brand GLP-1s, labs, devices and a real multi-disciplinary care team, though it publishes no state list at all.

The complete ladder is on the page before any intake, which almost nothing else here does: semaglutide $199 a month, $549 for three months, $999 for six, $1,788 for twelve; tirzepatide $299, $797, $1,494, $2,748. Read the long tiers correctly — each is a single upfront charge rather than a smaller monthly bill, so the advertised $149 means paying a full year before the first box ships. Disclosure is above average where it counts. Andrew Meds LLC is named with a Houston address, and the practice that writes the prescription is named separately as Dr Tel X in Kennewick, Washington. Coverage is all fifty states and DC, enumerated rather than claimed, and there is an oral tirzepatide alongside the injections. The gaps: the compounding pharmacy is never named, no time to first dose is published, and a period you have partly used is not refunded.